Evidence map›Paper›PMID 34265175›Full record

ArticleJournal of diabetes investigation2022

Bariatric surgery versus medical treatment in mildly obese patients with type 2 diabetes mellitus in Japan: Propensity score-matched analysis on real-world data.

Yosuke Seki, Kazunori Kasama, Renzo Yokoyama, Akihiro Maki, Hideharu Shimizu, Hyejin Park, Yoshimochi Kurokawa

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of diabetes investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yosuke SekiWeight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0965-7415
Kazunori KasamaWeight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, Tokyo, Japan.
Renzo YokoyamaWeight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, Tokyo, Japan.
Akihiro MakiJohnson & Johnson K.K. Medical Company, Tokyo, Japan.
Hideharu ShimizuJohnson & Johnson K.K. Medical Company, Tokyo, Japan.
Hyejin ParkJohnson and Johnson Medical, Seoul, Korea.
Yoshimochi KurokawaYotsuya Medical Cube, Tokyo, Japan.
Yotsuya Medical Cube · JPJohnson & Johnson (Brazil) · BR

Funding

Johnson & Johnson K.K. Medical Company
6 · The paper itself

Abstract

AIMS/

introductionTo compare glycemic control 1 year after treatment in patients with mildly obese (body mass index 27.5-34.9 kg/m MATERIALS AND

methodsA retrospective study using real-world data was carried out in electronic medical records from a tertiary care hospital and in the Japanese Medical Data Center Inc. claim database from 2008 to 2019. Each patient was propensity score-matched between the BS and the MT group by age, sex, body mass index, glycated hemoglobin and type 2 diabetes mellitus duration, and compared from the index date to the 1 year post-index.

resultsThe study included 78 patients in the BS group and 238 patients in the MT group. The mean body mass index in the BS and the MT group was 32.1 and 32.0 kg/m

conclusionsBS for mildly obese patients with type 2 diabetes mellitus is more clinically- and cost-effective than MT in Japan.

Indexed as

Bariatric SurgeryBody Mass IndexDiabetes Mellitus, Type 2FemaleGastrectomyGlycated HemoglobinGlycemic ControlHumansHypoglycemic AgentsJapanLaparoscopyMaleMetabolic SyndromeMiddle AgedObesityPropensity ScoreGlycated HemoglobinHypoglycemic AgentsBariatric surgeryMild obesityType 2 diabetes mellitus

Identifiers

PMID34265175
PMCPMC8756306
OpenAlexW3183115702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.